INTS
Intensity Therapeutics, Inc.
Set alert
3.40 USD +0.06 +1.80%
3.21 Day range 3.46
3.14 52-week range 33.00
- YTD
- -66.83%
- 1 year
- -89.70%
- Open
- 3.40
- Prev close
- 3.34
- Mkt cap
- 11.10M
- Vol
- 16.12K
- Avg vol
- 25.19K
- EPS
- -3.89
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.21
- High
- 3.46
- Forward P/E
- -1.66
- Beta
- 0.00
- Short ratio
- 3.05
- Inst. own
- 12.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.90
- 200-d avg
- 4.10
- 1y target
- 10.00
Financial health
Altman Z-Score
-10.08 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -1.2×
FY 2019 5y median -2.6× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.2×
FY 2019 5y median 1.2× FY 2025
P/FCF -1.5×
FY 2019 5y median -3.0× FY 2025
EV/EBITDA -0.2×
FY 2019 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -66.3%
FY 2019 5y median -33.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -97.7%
FY 2019 5y median -80.1% FY 2025
ROIC -99.9%
FY 2019 5y median -99.9% FY 2025
ROA -82.3%
FY 2019 5y median -151.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 27.8%
FY 2019 FY 2025
EPS (diluted) 70.7%
FY 2019 FY 2025
Free Cash Flow 39.3%
FY 2019 FY 2025
Financial Health
Current Ratio 5.9×
FY 2019 5y median 1.9× FY 2025
Quick Ratio 5.9×
FY 2019 5y median 1.9× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median -27.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31